Skip to main content

Command Palette

Search for a command to run...

AI Business Builds, Misinformation & Drug Discovery News

Updated
3 min read
AI Business Builds, Misinformation & Drug Discovery News
D
PhD in Computational Linguistics. I build the operating systems for responsible AI. Founder of First AI Movers, helping companies move from "experimentation" to "governance and scale." Writing about the intersection of code, policy (EU AI Act), and automation.

Quick Take: Dell's AI strategist emphasizes purposeful enterprise AI implementation over isolated experiments. Meanwhile, deepfake misinformation spreads in conflicts and AI-driven drug discovery advances through Harvard partnerships.

AI Business Builds, Misinformation Surge & Drug Discovery Breakthrough

TL;DR: Dell's AI strategist emphasizes purposeful enterprise implementation while deepfake misinformation spreads and AI-driven drug discovery advances through partnerships.

By Dr. Hernani Costa — June 28, 2025

Hello Movers—and good morning! Welcome to your daily First AI Movers Pro briefing—bringing you the freshest developments in AI that matter. Let's dive in.

Lead Story: AI Strategist at Dell Outlines Key Enterprise AI Focus

Dell Technologies' product leader in data science, Shruti Tiwari, shared insights on how enterprises are shaping AI strategies to boost efficiency and transformation, emphasising the importance of purposeful implementation rather than isolated experiments.

Why it matters: For AI-savvy organisations, this perspective is a timely reminder: strategy beats hype. Success lies in aligning AI initiatives with measurable business outcomes and scaling them thoughtfully. Product teams should take note—ask not just "Can we do it?" but "Does it move the needle?"

📰 In Other News

  • Deepfake Disinformation Spreads in Middle-East Conflict — AI-made combat footage and game clips masquerading as real are influencing online narratives in the Israel–Iran conflict. Experts recommend scrutinising clips under eight seconds for credibility checks.
  • XtalPi Partners with Harvard Professor for AI-Driven Drug Discovery — XtalPi joins forces with Harvard's Prof. Gregory Verdine to accelerate novel therapeutic development using an AI and robotics platform.

🤓 Fun Fact

Experts warn that AI deepfakes in conflicts often last fewer than eight seconds—a useful heuristic for spotting potential fabrications.

✍️ Conclusion

From AI strategy consulting at Dell to drug discovery through robotics and the urgent need to fight misinformation, today's briefing covers business, biotech, and digital truth. Which headline aligns with your area: enterprise adoption, healthcare innovation, or safeguarding information? Hit reply and let us know, or share this with your team to spark a strategic conversation.

Thanks for being part of our community—here's to making purpose-driven AI moves,

—The First AI Movers Pro Team

About the Author

Hi, I'm Dr. Hernani Costa, founder of First AI Movers. With a PhD and over 25 years of hands-on experience in technology, AI consulting, and Venture Building. I help leaders and founders create real business value through practical and ethical AI solutions. If you want to know more about what's possible, visit Core Ventures. Don't forget to follow us on LinkedIn. To partner with us: info@firstaimovers.com.

👉 Check out our newsletter recommendations.


Originally published at First AI Movers. Written by Dr. Hernani Costa, Founder and CEO of First AI Movers.

Subscribe to First AI Movers for daily AI insights and practical automation strategies for EU SME leaders. First AI Movers is part of Core Ventures.

Ready to automate your business? Book a call today!